Batko, B.; Schramm-Luc, A.; Skiba, D.S.; Mikolajczyk, T.P.; Siedlinski, M.
TNF-α Inhibitors Decrease Classical CD14hiCD16− Monocyte Subsets in Highly Active, Conventional Treatment Refractory Rheumatoid Arthritis and Ankylosing Spondylitis. Int. J. Mol. Sci. 2019, 20, 291.
https://doi.org/10.3390/ijms20020291
AMA Style
Batko B, Schramm-Luc A, Skiba DS, Mikolajczyk TP, Siedlinski M.
TNF-α Inhibitors Decrease Classical CD14hiCD16− Monocyte Subsets in Highly Active, Conventional Treatment Refractory Rheumatoid Arthritis and Ankylosing Spondylitis. International Journal of Molecular Sciences. 2019; 20(2):291.
https://doi.org/10.3390/ijms20020291
Chicago/Turabian Style
Batko, Bogdan, Agata Schramm-Luc, Dominik S. Skiba, Tomasz P. Mikolajczyk, and Mateusz Siedlinski.
2019. "TNF-α Inhibitors Decrease Classical CD14hiCD16− Monocyte Subsets in Highly Active, Conventional Treatment Refractory Rheumatoid Arthritis and Ankylosing Spondylitis" International Journal of Molecular Sciences 20, no. 2: 291.
https://doi.org/10.3390/ijms20020291
APA Style
Batko, B., Schramm-Luc, A., Skiba, D. S., Mikolajczyk, T. P., & Siedlinski, M.
(2019). TNF-α Inhibitors Decrease Classical CD14hiCD16− Monocyte Subsets in Highly Active, Conventional Treatment Refractory Rheumatoid Arthritis and Ankylosing Spondylitis. International Journal of Molecular Sciences, 20(2), 291.
https://doi.org/10.3390/ijms20020291